Multiple studies in mouse models demonstrated that NF-κB signaling promotes tumorigenesis in several cancer entities, including colitis-associated colon cancer [20], mammary tumors [21–23], DMBA/TPA-induced skin carcinogenesis [24], as well as Kras mutation-driven lung adenocarcinoma [25–27]. This evidence concerns the gene KRAS and lung adenocarcinoma.